Trading Halt
Filed with ASX · · 2 pages · English
On 6ix: 6ix.com/news/trading-halt-327
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings CallTrading in the securities of Botanix Pharmaceuticals Ltd (‘BOT’) will be halted at the request of BOT, pending the release of an announcement by BOT. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of: • the commencement of normal trading on Tuesday, 17 February 2026; or • the release of the announcement to the market. BOT’s request for a trading halt is
Botanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Pause in Trading
- Botanix Quarterly Activities Report and Appendix 4C Q2 FY26
- Botanix Quarterly Activities Report and Appendix 4C Q1 FY26
- Appendix 4E & Annual Report for the Year Ended 30 June 2025
- Response to ASX Aware Letter
Later from Botanix Pharmaceuticals
- Botanix Receives Capital Raise Commitments of A$45 Million
- Appendix 4D and Half Year Report
- S&P DJI Announces March 2026 Quarterly Rebalance
- Successful renegotiation of API supply agreement
- Botanix reaches term sheet agreement with 2nd API supplier
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals